ClassID:

94481

C07D239/10 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2 Oxygen or sulfur atoms

Recent Application in this class:
#1
20260098014
2026-04-09

IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF

#2
20240358702
2024-10-31

CYCLIC UREA KRAS INHIBITORS

#3
20240351966
2024-10-24

CLASS OF ALKYLPHENOL COMPOUNDS AND PREPARATION METHOD THEREFOR

#4
20240254385
2024-08-01

LUMINESCENT JANUS-TYPE, TWO-COORDINATED METAL COMPLEXES

#5
20240228442
2024-07-11

Solid state forms of mavacamten and process for preparation thereof

#6
20240082248
2024-03-14

PROCESS FOR PREPARATION OF MAVACAMTEN AND SOLID STATE FORMS THEREOF

#7
20240059660
2024-02-22

Uracil compound containing carboxylate fragment, preparation method therefor, and herbicidal composition and use thereof

#8
20240025862
2024-01-25

SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES

#9
20230273456
2023-08-31

OPTICALLY ACTIVE DEVICES

#10
20230273455
2023-08-31

OPTICALLY ACTIVE DEVICES

#11
20230124641
2023-04-20

CROSS-LINKED NUCLEOSIDE AND NUCLEOTIDE USING SAME

#12
20230115176
2023-04-13

Complement Modulators and Related Methods

#13
20230057197
2023-02-23

SOLID STATE FORMS OF MAVACAMTEN AND PROCESS FOR PREPARATION THEREOF

#14
20220380320
2022-12-01

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MIDDLE EAST RESPIRATORY SYNDROME

#15
20220220081
2022-07-14

Method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators

#16
20220033406
2022-02-03

CYCLOPENTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS

#17
20210286266
2021-09-16

Material for forming organic film, method for forming organic film, patterning process, and compound

#18
20210078955
2021-03-18

Sulfonamide derivative or pharmaceutically acceptable acid-addition salt

#19
20210009895
2021-01-14

Luminescent janus-type, two-coordinated metal complexes

#20
20200361910
2020-11-19

Process to prepare propylene amines and propylene amine derivatives

#21
20190322627
2019-10-24

Agricultural chemicals

#22
20180334439
2018-11-22

Antimicrobial Compounds And Methods Of Making And Using The Same

#23
20180179151
2018-06-28

Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof

#24
20180079728
2018-03-22

Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease

#25
20180050992
2018-02-22

Heterocyclic compounds and use thereof in medicine and in cosmetics

#26
20160368905
2016-12-22

Antiviral compounds and uses thereof

#27
20160332973
2016-11-17

Process for preparing antiviral compounds

#28
20160280621
2016-09-29

Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, mask blank provided with actinic ray-sensitive or radiation-sensitive film, photomask, pattern forming method, method for manufacturing electronic device, electronic device, compound, and method for producing compound

#29
20160209746
2016-07-21

Active light sensitive or radiation sensitive resin composition, active light sensitive or radiation sensitive film, mask blank provided with active light sensitive or radiation sensitive film, pattern forming method, method for manufacturing electronic device, electronic device and novel compound

#30
20160200854
2016-07-14

Reduction of aldehydes in amine catalysts

#31
20160031828
2016-02-04

Antimicrobial compounds and methods of making and using the same

#32
20150191437
2015-07-09

Process for preparing antiviral compounds

#33
20150099786
2015-04-09

Carboxamide compounds and their use as calpain inhibitors

#34
20150080570
2015-03-19

ALPHA,BETA-UNSATURATED MONOMERS CAPABLE OF MULTIMERIZATION IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME

#35
20150072949
2015-03-12

Pharmaceutical compounds

#36
20150056164
2015-02-26

Antiviral compounds and uses thereof

#37
20140303369
2014-10-09

Crystalline Pharmaceutical

#38
20140288017
2014-09-25

Catechol diethers as potent anti-HIV agents

#39
20140163221
2014-06-12

Process for the synthesis of cyclic alkylene ureas

#40
20140088125
2014-03-27

USE OF 3-CARBOXY-N-ETHYL-N,N-DIMETHYLPROPAN-1-AMINIUM SALTS IN THE TREATMENT OF CARDIOVASCULAR DISEASE

#41
20140066419
2014-03-06

Hydroxamic acid derivatives

#42
20130324494
2013-12-05

Pharmaceutical compounds

#43
20130245051
2013-09-19

Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1

#44
20130224149
2013-08-29

Process for preparing antiviral compounds

#45
20130150367
2013-06-13

Carboxamide compounds and their use as calpain inhibitors

#46
20130116269
2013-05-09

Cyclic N,N′-diarylthioureas and N,N′-diarylureas-androgen receptor antagonists, anticancer agent, method for preparation and use thereof

#47
20130012485
2013-01-10

ORGANIC COMPOUNDS

#48
20120309777
2012-12-06

Substituted 2-imidazolidones and analogs

#49
20120289471
2012-11-15

NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX

#50
20120202993
2012-08-09

Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates

#51
20120082646
2012-04-05

Antiviral compounds and uses thereof

#52
20120029193
2012-02-02

Polymerizable monomers

#53
20120028190
2012-02-02

Polymer, chemically amplified negative resist composition, and patterning process

#54
20110294839
2011-12-01

Polymorphs of lopinavir

#55
20110294754
2011-12-01

Pharmaceutical compounds

#56
20110281900
2011-11-17

Crystalline pharmaceutical

#57
20110269706
2011-11-03

Hydroxamic acid derivatives

#58
20110263582
2011-10-27

Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1

#59
20110224435
2011-09-15

PROCESS FOR PREPARATION OF AMORPHOUS LOPINAVIR

#60
20110086879
2011-04-14

Carboxamide compounds and their use as calpain inhibitors

#61
20100330032
2010-12-30

Heterocyclic antiviral compounds

#62
20100324045
2010-12-23

Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1

#63
20100298331
2010-11-25

Triazinone and diazinone derivatives useful as HSP90 inhibitors

#64
20100286146
2010-11-11

Carboxamide compounds and their use as calpain inhibitors

#65
20100280242
2010-11-04

Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates

#66
20100197680
2010-08-05

Lactam-substituted dicarboxylic acids and use thereof

#67
20100197676
2010-08-05

5-substituted-2-phenylamino benzamides as MEK inhibitors

#68
20100197675
2010-08-05

Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1

#69
20100113359
2010-05-06

DIMETHYLPHENOXY MODULATORS OF VIRAL PROTEASE ACTIVITY AND/OR PARASITIC ENZYME ACTIVITY

#70
20100087442
2010-04-08

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#71
20100069489
2010-03-18

L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX

#72
20100069446
2010-03-18

L-threonine derivatives of high therapeutic index

#73
20100004481
2010-01-07

L-Threonine derivatives of high therapeutic index

#74
20090264650
2009-10-22

Prophylactic/Therapeutic Agent for Diabetes

#75
20090233915
2009-09-17

5-Substituted-2-phenylamino benzamides as MEK inhibitors

#76
20090176766
2009-07-09

Imidazolidinone and imidazolidinethione derivatives

#77
20090069309
2009-03-12

Prostaglandin analogs

#78
20080287522
2008-11-20

BENZYLATED PDE4 INHIBITORS

#79
20080139811
2008-06-12

Retroviral protease inhibiting compounds

#80
20080090855
2008-04-17

Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators

#81
20070208181
2007-09-06

Benzylated PDE4 inhibitors

#82
20070161622
2007-07-12

Diamino alcohols and their use as renin inhibitor

#83
20070135426
2007-06-14

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

#84
20070027172
2007-02-01

Crystalline pharmaceutical

#85
20070010529
2007-01-11

Nitrogenous heterocyclic compounds and medical use thereof

#86
20060287293
2006-12-21

Heterocyclylakylamines as muscarinic receptor antagonists

#87
20060287244
2006-12-21

L-Threonine derivatives of high therapeutic index

#88
20060276461
2006-12-07

Prostaglandin analogs

#89
20060241017
2006-10-26

Compounds with high therapeutic index

#90
20060142612
2006-06-29

Arylsulfonamide derivatives

#91
20060111303
2006-05-25

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#92
20050267123
2005-12-01

6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade

#93
20050261287
2005-11-24

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

#94
20050239860
2005-10-27

Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade

#95
20050222184
2005-10-06

Process for preparing (s)-tetrahydro-a-(1-methylethyl)-2-oxo-1(2h)-pyrimidineacetic acid

#96
20050215783
2005-09-29

Thiourea compositions and uses thereof

#97
20050171085
2005-08-04

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

#98
20050124810
2005-06-09

Crystalline pharmaceutical

#99
20050124602
2005-06-09

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

#100
20050112693
2005-05-26

Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof

#101
20050090546
2005-04-28

Aspartic protease inhibitors

#102
20050085509
2005-04-21

Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient

#103
20050054534
2005-03-10

Substituted benzoylcyclohexane diones for use as herbicides

#104
15628476
2018-01-02

Dihydropyrimidinone derivatives

#105
13328121
2015-11-03

Crystalline lopinavir/surfactant adducts